FindTrial
Sign In

Effect of Protein Concentration on Human Embryo Development

Protein Concentration and Human Embryo Development

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03630848
Acronym
PCHED
Enrollment
1536
Registered
2018-08-15
Start date
2018-08-14
Completion date
2020-03-02
Last updated
2020-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Embryo Culture

Brief summary

Protein Concentration in Human Embryo Culture Media remains assigned to the manufacturers with no clear evidence on which concentration is ideal.

Interventions

OTHEREffect of Protein on Blastocyst Development

Embryo Development Related to The Protein Concentration

Sponsors

Banon IVF Center Assiut, Egypt
CollaboratorOTHER
Ibn Sina Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Intracytoplasmic sperm injection cycles

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Ongoing pregnancy rate12 weeks

Secondary

MeasureTime frameDescription
embryo developmenttwo months—
Blastocyst Formationtwo monthsnumber of formed blastocyst per fertilized oocyte
Clinical pregnancy rate7 weeks—
Implantation rate7 weeks—
Miscarriage rate12 weeks—

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026